IRONWOOD PHARMA INC CLASS A (IRWD)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for IRWD
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| IRWD | Founding Partner and Chief Investment Officer | 56 | ["Founding partner and chief investment officer of Sarissa Capital Management LP since 2011","Senior managing director at Icahn Capital LP from 2006 to 2011","Portfolio manager at Viking Global Investors and Morgan Stanley Investment Management","Board member of Attralus, Inc.","Chair of the board of directors of The Medicines Company and Sarissa Capital Acquisition Corp.","Member of the board of directors of Biogen Inc.","B.S. in mechanical engineering from MIT","M.S. and M.Phil. in mechanical engineering from Yale University","Interdisciplinary Ph.D. from Yale University","Significant experience overseeing operations and research and development of healthcare companies","Extensive experience as an investor, particularly with respect to healthcare companies","Broad healthcare industry knowledge"] | ["Governance and Nominating Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Dr. Denner has served as chair of the board of directors of The Medicines Company and Sarissa Capital Acquisition Corp., as well as a member of the board of directors of Biogen Inc. Dr. Denner earned his B.S. in mechanical engineering from Massachusetts Institute of Technology, an M.S. and M.Phil. in mechanical engineering from Yale University and an interdisciplinary Ph.D. from Yale University. Dr. Denner brings to the board significant experience overseeing the operations and research and development of healthcare companies and evaluating corporate governance matters. He also has extensive experience as an investor, particularly with respect to healthcare companies, and possesses broad healthcare industry knowledge.